VCYT - Veracyte - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VCYT is currently covered by 6 analysts with an average price target of $33.74. This is a potential upside of $6.58 (24.23%) from yesterday's end of day stock price of $27.16.

Veracyte's activity chart (see below) currently has 87 price targets and 90 ratings on display. The stock rating distribution of VCYT is 76.92% BUY, 19.23% SELL and 3.85% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 81.64% with an average time for these price targets to be met of 354 days.

Highest price target for VCYT is $45, Lowest price target is $28, average price target is $39.17.

Most recent stock forecast was given by MIKE MATSON from NEEDHAM on 08-May-2025. First documented stock forecast 20-Jun-2014.

Currently out of the existing stock ratings of VCYT, 20 are a BUY (76.92%), 5 are a SELL (19.23%), 1 are a HOLD (3.85%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$41

$13.84 (50.96%)

$51

16 days ago
(08-May-2025)

13/18 (72.22%)

$9.79 (31.37%)

383

Buy

$45

$17.84 (65.68%)

$34

1 months 28 days ago
(26-Mar-2025)

3/5 (60%)

$13.95 (44.93%)

546

Hold

$37

$9.84 (36.23%)

$38

5 months 19 days ago
(05-Dec-2024)

5/6 (83.33%)

$-5.84 (-13.63%)

102

Sell

$28

$0.84 (3.09%)

$26

6 months 6 days ago
(18-Nov-2024)

9/10 (90%)

$-8.71 (-23.73%)

76

Buy

$44

$16.84 (62.00%)

$40

6 months 16 days ago
(08-Nov-2024)

10/10 (100%)

$7.52 (20.61%)

173

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VCYT (Veracyte) average time for price targets to be met?

On average it took 354 days on average for the stock forecasts to be realized with a an average price target met ratio 81.64

Which analyst has the current highest performing score on VCYT (Veracyte) with a proven track record?

MASON CARRICO

Which analyst has the most public recommendations on VCYT (Veracyte)?

Mason Carrico works at STEPHENS and has 7 price targets and 6 ratings on VCYT

Which analyst is the currently most bullish on VCYT (Veracyte)?

Sandy Draper with highest potential upside - $28.8

Which analyst is the currently most reserved on VCYT (Veracyte)?

William Quirk with lowest potential downside - -$16.16

Veracyte in the News

Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up

Veracyte, Inc. VCYT delivered first-quarter 2025 earnings of 31 cents per share, which marked a stupendous improvement of 63.2% from the year-ago period’s figure of 19 cents. The bottom line beat the Zacks Consensus Estimate by 55%. The company-adjusted earnings per share (EPS) were 9 cents compared to the year-ago period’s loss of 2 cents...

Veracyte First Quarter 2025 Earnings: Beats Expectations

Veracyte (NASDAQ:VCYT) First Quarter 2025 Results Key Financial Results Revenue: US$114.5m (up 18% from 1Q 2024). Net income: US$7.05m (up from US$1.86m loss in 1Q 2024). Profit margin: 6.2% (up from net loss in 1Q 2024). EPS: US$0.09 (up from US$0.025 loss in 1Q 2024). AI is about to change healthcare. These 20 stocks are...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?